Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Radiation Oncology (London, England)|May 15, 2015
Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT studyLiam Welsh, Rafal Panek, Dualta McQuaid, et al.European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.Breeding Science|August 11, 2021
Optimal set of microsatellite markers required to detect illegitimate progenies in selected oil palm (<i>Elaeis guineensis</i> Jacq.) breeding crossesSiti Hazirah Zolkafli, Maizura Ithnin, Kuang-Lim Chan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancersKevin J Harrington, Eleni M Karapanagiotou, Victoria Roulstone, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2015
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid CancerMartin Schlumberger, Barbara Jarzab, Maria E Cabanillas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid CancerLori J Wirth, Marcia S Brose, Eric J Sherman, et al.The Lancet. Oncology|January 18, 2011
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialChristopher M Nutting, James P Morden, Kevin J Harrington, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignanciesEleni M Karapanagiotou, Victoria Roulstone, Katie Twigger, et al.Cancer|April 28, 2015
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentMaria E Cabanillas, Martin Schlumberger, Barbara Jarzab, et al.Thyroid : Official Journal of the American Thyroid Association|March 17, 2021
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid CancerKeith C Bible, Electron Kebebew, James Brierley, et al.Pageof 9